Office of Research & Development |
|
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01RX003060-01A2 |
| Title: | Therapeutic potential and the critical site of action of non-addicting glibenclamide in neuropathic pain |
| Principal Investigator: | J. Marc Simard |
| Location: | Baltimore, MD |
| Congressional District Code: | 7 |
| Research Service: | Rehabilitation R&D |
| Project Period: | April 2020 - March 2024 |
| FY 2021 Funding Amount: | $246,335 |
| Total Award Amount (all years): |
$1,015,340 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: BACKGROUND: Almost half of Veterans experience chronic pain, which is disproportionately greater than the 25 million Americans in the civilian population who suffer from significant chronic pain. Chronic pain is a common sequela of military- and terror-related injuries. The majority of battlefield wounds involve injuries to exposed limbs, resulting in high rates of neuropathic pain caused by damage to a peripheral nerve. Opioid use disorder and the ongoing “opioid epidemic” are driven in part by... |